Prognosis of idiopathic membranous nephropathy: A methodologic meta-analysis

Kidney International

Volumn 51, Issue 3, 1997, Pages 873-879

  Marx, Brigitte E ^a   Marx, Martin ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; MEMBRANOUS GLOMERULONEPHRITIS; METHODOLOGY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030928451     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.123     Document Type: Article

References (57)

1. WASSERSTEIN AG: Membranous glomerulonephritis, in The Principles and Practice of Nephrology (2nd ed), edited by JACOBSON HR, STRIKER GE, KLAHR S, St. Louis, Mosby-Year Book Inc., 1995, pp 149-154
2. ZUCCHELLI P, PASQUALI S: Membranous nephropathy, in Oxford Textbook of Clinical Nephrology, edited by CAMERON S, DAVISON AM, GRÜNFELD J-P, KERR D, RITZ E, Oxford, New York, Tokyo, Oxford University Press, 1992, pp 370-388
3. CAMERON JS: Membranous nephropathy - Still a treatment dilemma. N Engl J Med 327:638-639, 1992
4. REMUZZI G, BERTANI T, NEGRI M: Idiopathic membranous nephropathy. Lancet 342:1277-1280, 1993
5. COUCHOUD C, LAVILLE M, BOISSEL JP: Treatment of membranous nephropathy: A meta-analysis. Nephrol Dial Transplant 9:469-470, 1994
6. MARX BE, FEINSTEIN AR: Methodologic sources of prognostic inconsistencies in post-acute myocardial infarction. Am J Med 98:537-550, 1995
7. FEINSTEIN AR: Clinical Epidemiology: The Architecture of Clinical Research. Philadelphia, Pa, WB Saunders Co, 1985, chapt 11-17, pp 192-351
8. WASSON JH, SOX HC, NEFF RK, GOLDMAN L: Clinical prediction rules: Applications and methodological standards. N Engl J Med 313:793-797, 1985
9. KERNAN WN, FEINSTEIN AR, BRASS LM: A methodological appraisal of research on prognosis after transient ischemic attacks. Stroke 22:1108-1116, 1991
10. GERBARG ZB, HORWITZ RI: Resolving conflicting clinical trials: Guidelines for meta-analysis. J Clin Epidemiol 41:503-509, 1988
11. SACKS HS, BERRIER J, REITMAN D, ANCONA-BERK VA, CHALMERS TC: Meta-analyses of randomized controlled trials. N Engl J Med 316:450-455, 1987
12. DETSKY AS, NAYLOR CD, O'ROURKE K, MCGEER AJ, L'ABBE KA: Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol 45:255-265, 1992
13. EHRENREICH T, PORUSH JG, CHURG J, GARFINKEL L, GLABMAN S. GOLDSTEIN MH, GRISHMAN E, YUNIS SL: Treatment of idiopathic membranous nephropathy. N Engl J Med 295:741-746, 1976
14. COLLABORATIVE STUDY OF THE ADULT IDIOPATHIC NEPHROTIC SYNDROME: A controlled study of short-term prednisone treatment in adults with membranous nephropathy. N Engl J Med 301:1301-1306, 1979
15. NOEL LH, ZANETTI M, DROZ D, BARBANEL C: Long-term prognosis of idiopathic membranous glomerulonephritis. Am J Med 66:82-90, 1979
16. HOPPER J JR, TREW PA, BIAVA CG: Membranous nephropathy: Its relative benignity in women. Nephron 29:18-24, 1981
17. DAVISON AM, CAMERON JS, KERR DNS, OGG CS, WILKINSON RW: The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol 22:61-67, 1984
18. PONTICELLI C, ZUCCHELLI P, IMBASCIATI E, CAGNOLI L, POZZI C, PASSERINI P, GRASSI C, LIMIDO D, PASQUALI S, VOLPINI T, SASDELLI M, LOCATELLI F: Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 310:946-950, 1984
19. TU W-H, PETITTI DB, BIAVA CG, TULUNAY Ö, HOPPER J JR: Membranous nephropathy: Predictors of terminal renal failure. Nephron 36:118-124, 1984
20. ABE S, AMAGASAKI Y, KONISHI K, KATO E, IYORI S, SAKAGUCHI H: Idiopathic membranous glomerulonephritis: Aspects of geographical differences. J Clin Pathol 39:1193-1198, 1986
21. HONKANEN E: Survival in idiopathic membranous glomerulonephritis. Clin Nephrol 25:122-128, 1986
22. KIDA H, ASAMOTO T, YOKOYAMA H, TOMOSUGI N, HATTORI N: Long-term prognosis of membranous nephropathy. Clin Nephrol 25:64-69, 1986
23. DONADIO JV JR, TORRES VE, VELOSA JA, WAGONER RD, HOLLEY KE, OKAMURA M, ILSTRUP DM, CHU C-P: Idiopathic membranous nephropathy: The natural history of untreated patients. Kidney Int 33:708-715, 1988
24. MURPHY BF, FAIRLEY KF, KINCAID-SMITH PS: Idiopathic membranous glomerulonephritis: Long-term follow-up in 139 cases. Clin Nephrol 30:175-181, 1988
25. SHEARMAN JD, GENG YIN Z, AARONS I, SMITH PS, WOODROFFE AJ, CLARKSON AR: The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy. Clin Nephrol 30:320-329, 1988
26. ABE S, AMAGASAKI Y, IYORI S, KONISHI K, KATO E, SAKAGUCHI H: Significance of tobulointerstitial lesions in biopsy specimens of glomerulonephritic patients. Am J Nephrol 9:30-37, 1989
27. CATTRAN DC, DELMORE T, ROSCOE J, COLE E, CARDELLA C, CHARRON R, RITCHIE S, THE TORONTO GLOMERULONEPHRITIS STUDY GROUP: A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. N Engl J Med 320:210-215, 1989
28. PONTICELLI C, ZUCCHELLI P, PASSERINI P, CAGNOLI L, CESANA B, POZZI C, PASQUALI S, IMBASCIATI E, GRASSI C, REDAELLI B, SASDELLI M, LOCATELLI F: A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 320:8-13, 1989
29. WEHRMANN M, BOHLE A, BOGENSCHÜTZ O, EISSELE R, FREISLEDERER A, ÖHLSCHLEGEL C, SCHUMM G, BATZ C, GÄRTNER H-V: Long-term prognosis of chronic idiopathic membranous glomerulonephritis. Clin Nephrol 31:67-76, 1989
30. CAMERON JS, HEALY MJR, ADU D, THE MRC GLOMERULONEPHRITIS WORKING PARTY: The Medical Research Council Trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. Quart J Med 74:133-156, 1990
31. DURIN S, BARBANEL C, LANDAIS P, NOEL L-H, GRÜNFELD JP: Evolution a long terme des glomerulonephrites extra-membraneuses idiopathiques. Nephrologie 11:67-71, 1990
32. HAY NM, BAILEY RR, LYNN KL, ROBSON RA: Membranous nephropathy: A 19 years prospective study in 51 patients. NZ Med J 105:489-491, 1992
33. PEI Y, CATTRAN D, GREENWOOD C: Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. Kidney Int 42: 960-966, 1992
34. PONTICELLI C, ZUCCHELLI P, PASSERINI P, CESANA B, THE ITALIAN IDIOPATHIC MEMBRANOUS NEPHROPATHY TREATMENT STUDY GROUP: Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. N Engl J Med 327:599-603, 1992
35. LEE HS, KOH HI: Nature of progressive glomerulosclerosis in human membranous nephropathy. Clin Nephrol 39:7-16, 1993
36. SCHIEPPATI A, MOSCONI L, PERNA A, MECCA G, BERTANI T, GARATTINI S, REMUZZI G: Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 329:85-89, 1993
37. HONKANEN E, TÖRNROTH T, GRÖNHAGEN-RISKA C, SANKILA R: Long-term survival in idiopathic membranous glomerulonephritis: Can the course be clinically predicted? Clin Nephrol 41:127-134, 1994
38. TOTH T, TAKEBAYASHI S: Factors contributing to the outcome in 100 adult patients with idiopathic membranous glomerulonephritis. Int Urol Nephrol 26:93-106, 1994
39. CHURG J, SOBIN LH: Renal Disease: Classification and Atlas of Glomerular Diseases. Igaku-shoin, Tokyo, New York, 1994, pp 54-65
40. BARIÉTY J, DRUET P, LAGRUE G: Les glomérulopathies "extramembraneuses", Étude morphologique en microscopie optique, électronique et en immunofluorescence. Pathol Biol (Paris) 18:5-32, 1970
41. IDELSON BA, SMITHLINE N, SMITH GW, HARRINGTON JT: Prognosis in steroid-treated idiopathic nephrotic syndrome in adults. Arch Intern Med 137:891-896, 1977
42. HUNT LP, SHORT CD, MALLICK NP: Prognostic indicators in patients presenting with the nephrotic syndrome. Kidney Int 34:382-388, 1988
43. MACTIER R, BOULTON JONES JM, PAYTON CD, MCLAY A: The natural history of membranous nephropathy in the West of Scotland. Quart J Med 60:793-802, 1986
44. PASSERINI P, PASQUALI S, CESANA B, ZUCCHELLI P, PONTICELLI C: Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria. Nephrol Dial Transplant 4:525-529, 1989
45. MANOS J, SHORT CD, ACHESON EJ, DYER P, LAWLER W, MALLICK NP, WILLIAMS G: Relapsing idiopathic membranous nephropathy. Clin Nephrol 18:286-290, 1982
46. ROW PG, CAMERON JS, TURNER DR, EVANS DJ, WHITE RHR, OGG CS, CHANTLER C, BROWN CB: Membranous nephropathy. Long term follow-up and association with neoplasia. Quart J Med 174:207-239, 1975
47. COUNCIL ON THE KIDNEY IN CARDIOVASCULAR DISEASE, AMERICAN HEART ASSOCIATION: Criteria for the evaluation of the severity of established renal disease. Ann Intern Med 75:251-252, 1971
48. KAPLAN MH, FEINSTEIN AR: The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chron Dis 27:387-404, 1974
49. CHARLSON ME, POMPEI P, ALES KL, MACKENZIE CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis 40:373-383, 1987
50. BURNAND B, KERNAN WN, FEINSTEIN AR: Indexes and boundaries for "quantitative significance" in statistical decisions. J Clin Epidemiol 43:1273-1284, 1990
51. FEINSTEIN AR: Clinical biostatistics XI. Sources of chronology bias' in cohort statistics. Clin Pharmacol Ther 12:864-879, 1971
52. SIMS ACP: Importance of a high tracing-rate in long-term medical follow-up studies. Lancet 2:433, 1973
53. GREENLAND S: Response and follow-up bias in cohort studies. Am J Epidemiol 106:184-187, 1977
54. FEINSTEIN AR: Clinical Epidemiology: The Architecture of Clinical Research. Philadelphia, WB Saunders Co, 1985, chapt 17, pp 340-341
55. CONSORT GROUP: Improving the quality of reporting of randomized controlled trials. JAMA 276:637-639, 1996
56. SCHULZ KF: Randomised trials, human nature, and reporting guidelines. Lancet 348:596-598, 1996
57. IMPERIALE TF, GOLDFARB S, BERNS JS: Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials. J Am Soc Nephrol 5:1553-1558, 1995